Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 7 | 2024 | 306 | 1.480 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2025 | 131 | 1.270 |
Why?
|
| Pancreatic Neoplasms | 4 | 2025 | 715 | 1.000 |
Why?
|
| Smad4 Protein | 1 | 2025 | 26 | 0.930 |
Why?
|
| Liver Neoplasms | 1 | 2025 | 776 | 0.590 |
Why?
|
| Pluripotent Stem Cells | 1 | 2016 | 37 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 200 | 0.470 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 2365 | 0.380 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1117 | 0.360 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 87 | 0.350 |
Why?
|
| Neoplasm Metastasis | 3 | 2025 | 1061 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 454 | 0.320 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 295 | 0.300 |
Why?
|
| Signal Transduction | 3 | 2024 | 3502 | 0.290 |
Why?
|
| Mice | 11 | 2025 | 12269 | 0.280 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 554 | 0.230 |
Why?
|
| Neuroblastoma | 2 | 2021 | 396 | 0.230 |
Why?
|
| MicroRNAs | 4 | 2021 | 580 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2025 | 1338 | 0.220 |
Why?
|
| Chemokine CXCL9 | 1 | 2024 | 8 | 0.220 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2025 | 109 | 0.220 |
Why?
|
| Chemokine CXCL10 | 1 | 2024 | 23 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 2495 | 0.220 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2024 | 14 | 0.220 |
Why?
|
| RNA, Double-Stranded | 1 | 2024 | 22 | 0.220 |
Why?
|
| Alu Elements | 1 | 2024 | 15 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2024 | 80 | 0.220 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2021 | 40 | 0.210 |
Why?
|
| Animals | 12 | 2025 | 28155 | 0.200 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2023 | 40 | 0.190 |
Why?
|
| Loss of Heterozygosity | 1 | 2022 | 84 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2021 | 740 | 0.180 |
Why?
|
| Genes, p53 | 1 | 2022 | 108 | 0.180 |
Why?
|
| Interferons | 1 | 2022 | 112 | 0.180 |
Why?
|
| Gene Editing | 1 | 2022 | 51 | 0.170 |
Why?
|
| Ribosomes | 1 | 2021 | 102 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 636 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 404 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 308 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2022 | 235 | 0.160 |
Why?
|
| Morphogenesis | 1 | 2021 | 206 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 120 | 0.150 |
Why?
|
| Genome | 1 | 2022 | 407 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 103 | 0.150 |
Why?
|
| Pancreas | 1 | 2021 | 258 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 457 | 0.140 |
Why?
|
| HMGA2 Protein | 1 | 2018 | 15 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2020 | 202 | 0.140 |
Why?
|
| Disease Progression | 1 | 2022 | 1531 | 0.140 |
Why?
|
| Neoplasms | 2 | 2022 | 3169 | 0.130 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2016 | 13 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 136 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 103 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2018 | 219 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 302 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 555 | 0.120 |
Why?
|
| Humans | 14 | 2025 | 93515 | 0.120 |
Why?
|
| Protein Domains | 1 | 2016 | 161 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 200 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 65 | 0.120 |
Why?
|
| Gene Amplification | 1 | 2016 | 140 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 319 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1587 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2016 | 517 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2016 | 784 | 0.110 |
Why?
|
| Lung | 1 | 2021 | 1366 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2016 | 1133 | 0.100 |
Why?
|
| Mutation | 1 | 2025 | 4272 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2012 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2012 | 74 | 0.090 |
Why?
|
| Wound Healing | 1 | 2013 | 373 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 531 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2021 | 1691 | 0.070 |
Why?
|
| Chromosome Deletion | 2 | 2022 | 214 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 1775 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2022 | 352 | 0.070 |
Why?
|
| Base Sequence | 1 | 2012 | 2220 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 556 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 217 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1799 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2755 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2024 | 26 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 1173 | 0.050 |
Why?
|
| Retroelements | 1 | 2024 | 50 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2022 | 970 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2024 | 70 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2024 | 164 | 0.050 |
Why?
|
| Tandem Repeat Sequences | 1 | 2022 | 31 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2022 | 37 | 0.050 |
Why?
|
| Chromosomes | 1 | 2022 | 91 | 0.050 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2021 | 7 | 0.040 |
Why?
|
| Nucleotides | 1 | 2022 | 93 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 28 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2022 | 98 | 0.040 |
Why?
|
| Macrophages | 1 | 2024 | 610 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 66 | 0.040 |
Why?
|
| Interleukin-33 | 1 | 2021 | 28 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 105 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 756 | 0.040 |
Why?
|
| Genotype | 1 | 2024 | 1866 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 863 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 696 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 440 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 665 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 123 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2544 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 39 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 878 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 98 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 848 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 526 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2013 | 28 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3435 | 0.030 |
Why?
|
| Regeneration | 1 | 2013 | 159 | 0.020 |
Why?
|
| Extremities | 1 | 2013 | 176 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2026 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2013 | 299 | 0.020 |
Why?
|
| Male | 2 | 2021 | 44557 | 0.020 |
Why?
|
| Female | 2 | 2021 | 48702 | 0.010 |
Why?
|